Image of coins with M and A notes
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Transport solutions provider Engenco Ltd (ASX:EGN) has told its shareholders to “take no action” in response to a proposed off-market takeover by Elph Investments, which itself is part of mining equipment manufacturer Elphinstone Group.

The latter already holds a 68.53% stake in Engenco and is offering 30.5 cents for each Engenco share; a premium of 45.2% to the price at March 6’s end of trade.

However, after the offer was announced, Engenco’s board published its own advice: Saying shareholders should sit tight until further information was offered, with Engenco set to release a Target statement in response.

The company said an ‘Independent Board Committee’ had been established from shareholders independent of Elphinstone. Baker McKenzie was appointed as legal advisor.

A recommendation from independent directors, together with an Independent Expert’s Report, will be included in the Target Statement; shareholders have been advised to await this before taking any steps concerning the offer.

Engenco specialises in providing products and solutions for transportation, with segments including ‘Drivetrain,’ which offers technical services to industries like mining, oil and gas, rail, defense, and marine, and ‘Convair,’ which manufactures bulk pneumatic road tankers and mobile silos for carrying and storing dry bulk materials.

EGN‘s share price was last 29.5 cents – a rise of 40% since market open.

Join the discussion: See what HotCopper users are saying about Engenco Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

egn by the numbers
More From The Market Online
Hong Kong coastline drone shot

Paradigm Biopharma activates Hong Kong trial site for Phase III osteo trial for iPPS

Paradigm Biopharmaceuticals (ASX:PAR) has kicked off the screening process for participants with osteoarthritis ahead of the company’s Hong Kong-based
A HotCopper-branded graphic image which reads "The HotList Top 10: This week's most watchlisted ASX stocks" in front of an ASX chart image faded in the background.

HotList stocks: Northern Star, Immutep, Lodestar, and other trending companies in Week 12

Good afternoon, and welcome to the HotCopper HotList column.

Juno identifies early promise at Mount Ida gold anomaly

Juno Minerals has obtained promising results from drilling of a significant gold anomaly at the Mt…

Basin Energy receives government funding to fast-track Sybella-Barkly REE studies

Basin Energy has landed two separate funding packages to advance its Sybella-Barkly project in Queensland.